Diaminopyrimidines, diaminopyridines and diaminopyridazines as histamine H4 receptor modulators

被引:4
作者
Savall, Brad M. [1 ]
Meduna, Steven P. [1 ]
Tays, Kevin [1 ]
Cai, Hui [1 ]
Thurmond, Robin L. [1 ]
McGovern, Patricia [1 ]
Gaul, Michael [1 ]
Zhao, Bao-Ping [1 ]
Edwards, James P. [1 ]
机构
[1] Janssen Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA
关键词
Histamine H-4; Antagonists; Pyrimidine; Pyridine; Pyridazine; ANTAGONISTS; LIGANDS;
D O I
10.1016/j.bmcl.2014.12.027
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Previously disclosed H-4 receptor modulators, the triamino substituted pyridines and pyrimidines, contain a free primary amino (-NH2) group. In this Letter we demonstrate that an exocyclic amine (NH2) is not needed to maintain affinity, and also show a significant divergence in the SAR of the pendant diamine component. These des-NH2 azacycles also show a distinct functional spectrum, that appears to be influenced by the diamine component; in the case of the 1,3-amino pyrimidines, the preferred diamine is the amino pyrrolidine instead of the more common piperazines. Finally, we introduce 3,5-diamino pyridazines as novel histamine H-4 antagonists. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:956 / 959
页数:4
相关论文
共 50 条
  • [21] Design and synthesis of histamine H3/H4 receptor ligands with a cyclopropane scaffold
    Watanabe, Mizuki
    Kobayashi, Takaaki
    Ito, Yoshihiko
    Fukuda, Hayato
    Yamada, Shizuo
    Arisawa, Mitsuhiro
    Shuto, Satoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (23-24) : 3630 - 3633
  • [22] Histamine H4 receptors in the gastrointestinal tract
    Deiteren, A.
    De Man, J. G.
    Pelckmans, P. A.
    De Winter, B. Y.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (05) : 1165 - 1178
  • [23] Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening
    Levoin, Nicolas
    Labeeuw, Olivier
    Billot, Xavier
    Calmels, Thierry
    Danvy, Denis
    Krief, Stephane
    Berrebi-Bertrand, Isabelle
    Lecomte, Jeanne-Marie
    Schwartz, Jean-Charles
    Capet, Marc
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 565 - 572
  • [24] The histamine H4 receptor as a new target for treatment of canine inflammatory skin diseases
    Rossbach, Kristine
    Stark, Holger
    Sander, Kerstin
    Leurs, Rob
    Kietzmann, Manfred
    Baeumer, Wolfgang
    VETERINARY DERMATOLOGY, 2009, 20 (5-6) : 555 - 561
  • [25] Synthesis and Functional Characterization of Imbutamine Analogs as Histamine H3 and H4 Receptor Ligands
    Geyer, Roland
    Kaske, Melanie
    Baumeister, Paul
    Buschauer, Armin
    ARCHIV DER PHARMAZIE, 2014, 347 (02) : 77 - 88
  • [26] Targeting the Histamine H4 Receptor: Future Drugs for Inflammatory Diseases
    Correa, Michelle Fidelis
    dos Santos Fernandes, Joao Paulo
    CURRENT ORGANIC CHEMISTRY, 2018, 22 (17) : 1663 - 1672
  • [27] Profiling of histamine H4 receptor agonists in native human monocytes
    Gschwandtner, M.
    Koether, B.
    Werfel, T.
    Stark, H.
    Gutzmer, R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (01) : 136 - 143
  • [28] Role of the second and third extracellular loops of the histamine H4 receptor in receptor activation
    Brunskole, Irena
    Strasser, Andrea
    Seifert, Roland
    Buschauer, Armin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 384 (03) : 301 - 317
  • [29] Triazole Ligands Reveal Distinct Molecular Features That Induce Histamine H4 Receptor Affinity and Subtly Govern H4/H3 Subtype Selectivity
    Wijtmans, Maikel
    de Graaf, Chris
    de Kloe, Gerdien
    Istyastono, Enade P.
    Smit, Judith
    Lim, Herman
    Boonnak, Ratchanok
    Nijmeijer, Saskia
    Smits, Rogier A.
    Jongejan, Aldo
    Zuiderveld, Obbe
    de Esch, Iwan J. P.
    Leurs, Rob
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1693 - 1703
  • [30] Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands
    Kottke, Tim
    Sander, Kerstin
    Weizel, Lilia
    Schneider, Erich H.
    Seifert, Roland
    Stark, Holger
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 654 (03) : 200 - 208